Singapore: MMRGlobal received confirmation of the filings of a divisional application for its antibody technology in Jap...
Singapore: In a bid to further foster new drug research for drug resistant tuberculosis (TB), Wellcome Trust has collabo...
Singapore: Johnson & Johnson plans to establish four regional innovation centers in major life sciences communities ...
Singapore: Amgen has received positive results from its global Phase 2 clinical trial of AMG 334, a fully human monoclon...
Singapore: OccuRx, an Australian biopharmaceutical company developing a new class of drugs to prevent health burden due ...
Singapore: US-based Nektar Therapeutics has revealed positive preclinical data for NKTR-214, a novel cancer immunotherap...
Singapore: A group of international researchers, including from University of Melbourne, have discovered a new class of ...
Singapore: India-based Suven Lifescinces has secured patents for its new chemical entities (NCEs) from Japan, China, New...
Singapore: Israel-based D-Pharm has recieved new patent in the US and China, related to composition and use of THR-18, a...
Singapore: Australia based Novogen's lead candidate, TRXE-009, developed for the treatment of brain cancers, has shown t...
Singapore: A team of scientists from Cancer Science Institute of Singapore (CSI Singapore) at the National University of...
Singapore: Certara, a drug development and drug safety consultancy firm has launched its D360 software in Japan for prov...
Singapore: Chinese biotechnology firm, 3SBio, has signed an exclusive license with Korean firm, DiNonA for the develop...
Singapore: Australia-based clinical-stage drug development company, Invion, initiated and commenced patient enrolment in...
Singapore: Breast cancer therapeutics pipeline has higher innovation in first-in-class molecules, with many new technolo...
Singapore: Ascend Biopharmaceuticals, a Melbourne-based immunotherapy company, plans to begin a Phase 2 clinical trial o...
Singapore: Singapore's biopharmaceutical company, MerLion Pharmaceuticals, has recieved positive results from a phase 2 ...
Singapore: Ally Bridge Group (ABG), a global healthcare-focused investment platform, has expanded its global biopharmace...
